Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
-
Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design
-
Brilinta significantly reduced the rate of the composite of stroke and death in patients who had an acute ischaemic stroke or transient ischaemic attack in the Phase III THALES trial
-
Brilinta granted FDA Priority Review for the reduction of subsequent stroke in patients who had an acute ischemic stroke or transient ischemic attack
-
Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer
-
Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
-
Breztri Aerosphere significantly reduced rate of moderate or severe COPD exacerbations in Phase III ETHOS trial
-
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
-
Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials
-
AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020
Latest articles and press releases
All of our latest press releases and articles are available to explore
